Padnarsertib

CAS No.	1643913-93-2	Cat. No.	BCP10637
Name	Padnarsertib
Synonyms	KPT9274;PAK4-IN-1;KPT-9274;KPT 9274; PAK4-IN-1; PAK4-IN 1; PAK4-IN1;
Formula	C35H29F3N4O3	M. Wt	610.63

Description	Padnarsertib is a potent, selective and dual PAK4/NAMPT inhibitor. KPT-9274 interferences with PAK4/NAMPT signaling pathways, which results in reduction of G2-M transit as well as induction of apoptosis and decrease in cell invasion and migration in several human RCC cell lines. Mechanistic studies demonstrate that inhibition of the PAK4 pathway by KPT-9274 attenuates nuclear β-catenin as well as the Wnt/β-catenin targets cyclin D1 and c-Myc. KPT-9274 demonstrated the expected on-target effects in this mouse model. KPT-9274 is being evaluated in a phase I human clinical trial in solid tumors and lymphomas, which will allow this data to be rapidly translated into the clinic for the treatment of RCC.
Pathways	Protease/Metabolic Enzyme Cell Cycle/DNA Damage
Targets	Nampt PAK

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.